Clobazam Tablet
Product Images NDC 67877-664

11 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 67877-664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clob-10mg-100s Bottle (Clob 10mg 100s Bottle)

FDA Label Image

Clob-10mg-500s Bottle (Clob 10mg 500s Bottle)

FDA Label Image

Clob-10mg-blister-carton (Clob 10mg Blister Carton)

FDA Label Image

Clob-10mg-blister (Clob 10mg Blister)

Clob-10mg-blister (Clob 10mg Blister)
Label for Clobazam Tablet 10 mg, a prescription oral tablet manufactured for Ascend Laboratories, LLC. The label includes the controlled substance schedule IV symbol and a barcode, with manufacturing stated as made in India. Lot and expiration date fields are placeholder text.*
FDA Label Image

Clob 20mg 100scont

FDA Label Image

Clob 20mg 10sblis

FDA Label Image

Clob 20mg 10scar

FDA Label Image

Clob 20mg 500scont

FDA Label Image

Clob01.jpg (Clob01)

Clob01.jpg (Clob01)
Chemical structure of Clobazam showing its molecular arrangement including a chlorinated benzodiazepine ring system with attached methyl and phenyl groups.*
FDA Label Image

Clob_02 (Clob02)

Clob_02 (Clob02)
A bar chart showing the percentage reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High dose groups with sample sizes indicated. The reduction ranges from -12.1% for Placebo to -68.3% for High dose, with statistical significance markers noted.*
FDA Label Image

Clob_03 (Clob03)

Clob_03 (Clob03)
A bar chart showing the proportion of patients (%) versus the reduction in weekly drop seizure frequency from baseline (%). The chart compares four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High doses across various seizure reduction ranges.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.